British Heart Foundation to tackle the suffering and devastation caused by heart and circulatory diseases with historic research award
31 August, 2018
Leaf Expression Systems, a contract biopharmaceutical development business specialising in plant-based expression of proteins, metabolites and complex natural products, announced today announced that its multi-million pound purpose-built facility on the Norwich Research Park is now fully operational amidst growing interest worldwide in its potentially game-changing plant transient expression technology, Hypertrans®
22 August, 2018
Antipsychotics, breast cancer drug, oral contraceptives and MMR vaccine make the top ten
16 August, 2018
Sygnature Discovery, a leading independent provider of integrated drug discovery and pre-clinical services and expertise, has today announced the next stage in its ambitious expansion plans with the addition of a new facility located at Alderley Park in Cheshire.
15 August, 2018
The non-antibiotic compounds, tested in animal models, prevented production of gut byproduct linked to heart attack and stroke in humans
13 August, 2018
The topic of this month’s newsletter from Drug Discovery Today is “Models”
10 August, 2018
The current standard-of-care for millions of patients across the world with diabetic macular edema (DME) relies on invasive intravitreal injections or implants, both of which are associated with serious risks and side effects. An oral DME treatment could not only provide a less intrusive and safer choice but could also pave the way for prophylactic treatment.
07 August, 2018
The therapeutic use of mesenchymal stem cells or MSCs was first investigated in humans in 1995, generating a great deal of early enthusiasm about their promise as easily manufactured allogeneic cellular medicines. Since 1995, MSCs have become one of the most clinically studied experimental cell therapy platforms in the world. After more than 20 years of MSC clinical research, which has not yet resulted in an FDA-approved therapy, many people have questioned whether they can fulfil their therapeutic promise.
02 August, 2018